相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A pilot to assess target engagement of terazosin in Parkinson's disease
Jordan L. Schultz et al.
PARKINSONISM & RELATED DISORDERS (2022)
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease
Brage Brakedal et al.
CELL METABOLISM (2022)
Fighting Parkinson's disease: The return of the mitochondria
Kevin Zambrano et al.
MITOCHONDRION (2022)
Mitochondria and Parkinson's Disease: Clinical, Molecular, and Translational Aspects
Max Borsche et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP+-induced Parkinson's disease
Huiping Qi et al.
NEUROSCIENCE LETTERS (2021)
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease A Randomized Clinical Trial
Tanya Simuni et al.
JAMA NEUROLOGY (2021)
Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson's Disease
Peipei Li et al.
METABOLITES (2021)
Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model
Hu Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease-A Pilot Study
Abhishek G. Sathe et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson's disease
Phillippa J. Carling et al.
PROGRESS IN NEUROBIOLOGY (2020)
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease A Phase 2 Randomized Clinical Trial
Fernando. L. Pagan et al.
JAMA NEUROLOGY (2020)
Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study
Thomas Payne et al.
BMJ OPEN (2020)
Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease
Alan Whone et al.
BRAIN (2019)
Potential Markers of Progression in Idiopathic Parkinson's Disease Derived From Assessment of Circular Gait With a Single Body-Fixed-Sensor: A 5 Year Longitudinal Study
M. Encarna Mico-Amigo et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2019)
Progressive Gait Deficits in Parkinson's Disease: A Wearable-Based Biannual 5-Year Prospective Study
Markus A. Hobert et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Gait analysis with wearables predicts conversion to parkinson disease
Silvia Del Din et al.
ANNALS OF NEUROLOGY (2019)
An omics-based strategy using coenzyme Q10 in patients with Parkinson's disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial
Jannik Prasuhn et al.
NEUROLOGICAL RESEARCH AND PRACTICE (2019)
The Role of Movement Analysis in Diagnosing and Monitoring Neurodegenerative Conditions: Insights from Gait and Postural Control
Christopher Buckley et al.
BRAIN SCIENCES (2019)
Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy
Ruqi Tang et al.
GUT (2018)
Step length predicts executive dysfunction in Parkinson's disease: a 3-year prospective study
Marianna Amboni et al.
JOURNAL OF NEUROLOGY (2018)
Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease
Alexandra Isabel Rosa et al.
MOLECULAR NEUROBIOLOGY (2018)
Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson's Disease
Stewart E. Graham et al.
METABOLITES (2018)
Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease
Sara Moreira et al.
EXPERIMENTAL NEUROLOGY (2017)
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Dilan Athauda et al.
LANCET (2017)
Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson's Disease: Modulation of Mitochondrial Perturbations
Noha F. Abdelkader et al.
MOLECULAR NEUROBIOLOGY (2016)
Comparative assessment of different methods for the estimation of gait temporal parameters using a single inertial sensor: application to elderly, post-stroke, Parkinson's disease and Huntington's disease subjects
Diana Trojaniello et al.
GAIT & POSTURE (2015)
UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2G2019S carriers and in vivo
Heather Mortiboys et al.
NEUROLOGY (2015)
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
Anthony H. V. Schapira et al.
LANCET (2014)
Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease
Heather Mortiboys et al.
BRAIN (2013)
Body-worn motion sensors detect balance and gait deficits in people with multiple sclerosis who have normal walking speed
R. I. Spain et al.
GAIT & POSTURE (2012)
Tauroursodeoxycholic Acid Prevents MPTP-Induced Dopaminergic Cell Death in a Mouse Model of Parkinson's Disease
M. Castro-Caldas et al.
MOLECULAR NEUROBIOLOGY (2012)
Ursodeoxycholic acid suppresses mitochondria-dependent programmed cell death induced by sodium nitroprusside in SH-SY5Y cells
Hong Sung Chun et al.
TOXICOLOGY (2012)
Safety, Tolerability, and Cerebrospinal Fluid Penetration of Ursodeoxycholic Acid in Patients With Amyotrophic Lateral Sclerosis
Gareth J. Parry et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Multinuclear Magnetic Resonance Spectroscopy for in Vivo Assessment of Mitochondrial Dysfunction in Parkinson's Disease
Claire Henchcliffe et al.
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
Susan N. Cullen et al.
JOURNAL OF HEPATOLOGY (2008)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study
Kallol Ray Chaudhuri et al.
MOVEMENT DISORDERS (2006)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Estimation of gait cycle characteristics by trunk accelerometry
R Moe-Nilssen et al.
JOURNAL OF BIOMECHANICS (2004)
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'
KN Lazaridis et al.
JOURNAL OF HEPATOLOGY (2001)
分享论文
